USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Slayback Pharma LLC

USPTO PatentsView assignee record - 39 granted patents across 3 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Slayback ranks #8,291 of 49,997 tracked US assignees by granted-patent volume, with 39 patents across 3 technology areas.

#8,291
of 49,997 US assignees by volume
Top 19%
by Innovation Score (47.4/100)
14.2
avg claims per patent
+3000%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8291 · Foreign Corporation #8,291 · 39 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 39 grants
  • UPPER-Q #8,291/49,997
  • PHOTO-FINISH Sanyo Special Steel
  • CPC-NARROW A61K · 3 areas
  • INNOV-PAR 47.4/100
  • CLAIMS-RICH 14.2 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +3000% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sanyo Special Steel Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Slayback’s 47.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Slayback

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Slayback's Innovation Score is 47.4/100 (top 19% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Slayback?

Each dot is one of Slayback’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Slayback’s own 14.2 claims/patent is at or below the 15.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Slayback vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 38.939.039.03939.039.039.1 5101520 Granted patents (volume) Avg claims / patent Sanyo Special Steel Co., Ltd. - 39, 7.74Sanyo Special Ste…Schreiner Group GmbH & Co. KG - 39, 17.46Schreiner Group &…SetPoint Medical Corporation - 39, 17.67Setpoint MedicalSingapore University of Technology and Design - 39, 16.44Singapore Univers…Slice, Inc. - 39, 9.64SliceStimwave Technologies Incorporated - 39, 18.49Stimwave Incorpor…T-max (HANGZHOU) Technology, Co., Ltd. - 39, 15.44T-max (Hangzhou)…Thunder Power Hong Kong Ltd. - 39, 12.87Thunder Power Hon…Slayback Pharma LLC - 39, 14.18Slayback Pharma
Slayback vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Slayback's grants concentrate

Slayback Pharma LLC is a focused PatentsView assignee: 3 CPC subclasses with 97.4% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2024 (12 grants) versus a trough of 1 in 2019. By volume, Slayback sits between Sanyo Special Steel Co., Ltd. and Thunder Power Hong Kong Ltd..

Slayback's three-year grant acceleration

Slayback Pharma LLC shows 24 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Slayback's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Slayback holds 39 patents at rank #8,290, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Slayback

By rank, the assignees closest to #8,290 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Slayback's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Slayback, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Slayback ranks #569 of 7,163 assignees by patent count in that subclass.

Slayback's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 19% higher than 81% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

051015 2019202020212022202320242025 7
USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
Slayback Pharma LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 1 2.6%
2020 2 5.1%
2021 5 12.8%
2022 2 5.1%
2023 10 25.6%
2024 12 30.8%
2025partial year 7 17.9%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Slayback Pharma LLC's patent record in context - here's where to go next.

  • Slayback Pharma LLC's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 97.4% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #8,291 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Slayback Pharma LLC against Sanyo Special Steel Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 47.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.